PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 232 filers reported holding PDL BIOPHARMA INC in Q3 2014. The put-call ratio across all filers is 1.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $490,000 | -30.2% | 69,590 | -23.6% | 0.04% | -32.8% |
| Q4 2014 | $702,000 | +110.2% | 91,089 | +103.5% | 0.06% | +100.0% |
| Q3 2014 | $334,000 | -2.6% | 44,767 | +26.4% | 0.03% | -5.9% |
| Q2 2014 | $343,000 | +1.8% | 35,407 | -12.6% | 0.03% | -8.1% |
| Q1 2014 | $337,000 | +17.8% | 40,502 | +19.7% | 0.04% | +12.1% |
| Q4 2013 | $286,000 | -41.3% | 33,848 | -44.6% | 0.03% | -48.4% |
| Q3 2013 | $487,000 | +3.4% | 61,064 | 0.0% | 0.06% | -4.5% |
| Q2 2013 | $471,000 | – | 61,064 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Chapters Capital Management LLC | 119,700 | $254,000 | 0.43% |
| GSA CAPITAL PARTNERS LLP | 1,587,756 | $3,366,000 | 0.20% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 60,901 | $129,110,000 | 0.14% |
| Acrospire Investment Management LLC | 129,480 | $274,000 | 0.11% |
| SECOR Capital Advisors, LP | 410,323 | $870,000 | 0.11% |
| RBF Capital, LLC | 251,421 | $540,000 | 0.08% |
| Park West Asset Management LLC | 400,000 | $848,000 | 0.07% |
| MACKENZIE FINANCIAL CORP | 4,687,825 | $9,938,000 | 0.06% |
| CIGNA INVESTMENTS INC /NEW | 261,533 | $554,000,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 5,503,285 | $11,665,000 | 0.06% |